These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 34757999)
41. Incisional hernia repair with a slowly absorbable P4HB mesh: what happens after the mesh disappears? A retrospective longitudinal clinical study. Layer T; Benammi S; Dubuisson V; Manfredelli S; Passot G; Charleux-Muller D; Renard Y; Ortega-Deballon P; Romain B Hernia; 2023 Apr; 27(2):387-394. PubMed ID: 35536373 [TBL] [Abstract][Full Text] [Related]
42. Outcomes of biosynthetic absorbable mesh use in high risk CDC Class I ventral hernia repair: a single surgeon series. Smith A; Slater K Hernia; 2022 Feb; 26(1):97-108. PubMed ID: 34105003 [TBL] [Abstract][Full Text] [Related]
43. Short-term outcomes of heavyweight versus mediumweight synthetic mesh in a retrospective cohort of clean-contaminated and contaminated retromuscular ventral hernia repairs. Ellis RC; Maskal SM; Messer N; Miller BT; Petro CC; Prabhu AS; Rosen MJ; Zheng X; Beffa LRA Surg Endosc; 2024 Jul; 38(7):4006-4013. PubMed ID: 38862822 [TBL] [Abstract][Full Text] [Related]
44. What results can be expected one year after complex incisional hernia repair with biosynthetic mesh? Vauclair E; Bert M; Facy O; Cheynel N; Rat P; Ortega-Deballon P J Visc Surg; 2021 Apr; 158(2):111-117. PubMed ID: 33454303 [TBL] [Abstract][Full Text] [Related]
45. Comparative Effectiveness Analysis of Resorbable Synthetic Onlay and Biologic Intraperitoneal Mesh for Abdominal Wall Reconstruction: A 2-Year Match-Paired Analysis. Othman S; Christopher A; Patel V; Jia H; Mellia JA; Kovach SJ; Fischer JP Plast Reconstr Surg; 2022 May; 149(5):1204-1213. PubMed ID: 35311754 [TBL] [Abstract][Full Text] [Related]
46. Comparative study between biologic porcine dermal meshes: risk factors of postoperative morbidity and recurrence. Romain B; Story F; Meyer N; Delhorme JB; Brigand C; Rohr S J Wound Care; 2016 Jun; 25(6):320-5. PubMed ID: 27286664 [TBL] [Abstract][Full Text] [Related]
47. First human use of hybrid synthetic/biologic mesh in ventral hernia repair: a multicenter trial. Bittner JG; El-Hayek K; Strong AT; LaPinska MP; Yoo JS; Pauli EM; Kroh M Surg Endosc; 2018 Mar; 32(3):1123-1130. PubMed ID: 28726148 [TBL] [Abstract][Full Text] [Related]
48. Complex Ventral Hernia Repair with Acellular Dermal Matrices: Clinical and Quality of Life Outcomes. Roth JS; Zachem A; Plymale MA; Davenport DL Am Surg; 2017 Feb; 83(2):141-147. PubMed ID: 28228200 [TBL] [Abstract][Full Text] [Related]
49. The use of synthetic mesh in contaminated and infected abdominal wall repairs: challenging the dogma-A long-term prospective clinical trial. Birolini C; de Miranda JS; Tanaka EY; Utiyama EM; Rasslan S; Birolini D Hernia; 2020 Apr; 24(2):307-323. PubMed ID: 31493051 [TBL] [Abstract][Full Text] [Related]
50. Hernia recurrence and infection rate in elective complex abdominal wall repair using biologic mesh. Kanitra JJ; Hess AL; Haan PS; Anderson CI; Kavuturu S BMC Surg; 2019 Nov; 19(1):174. PubMed ID: 31752803 [TBL] [Abstract][Full Text] [Related]
51. Systematic review and meta-analysis of the repair of potentially contaminated and contaminated abdominal wall defects. Atema JJ; de Vries FE; Boermeester MA Am J Surg; 2016 Nov; 212(5):982-995.e1. PubMed ID: 27443425 [TBL] [Abstract][Full Text] [Related]
52. Evaluation of 30-day outcomes for open ventral hernia repair using self-gripping versus nonself-gripping mesh. Bahraini A; Hsu J; Cochran S; Campbell S; Overby DW; Phillips S; Prabhu A; Perez A Surg Endosc; 2024 May; 38(5):2871-2878. PubMed ID: 38609587 [TBL] [Abstract][Full Text] [Related]
53. The use of synthetic mesh in patients undergoing ventral hernia repair during colorectal resection: risk of infection and recurrence. El-Gazzaz GH; Farag SH; El-Sayd MA; Mohamed HH Asian J Surg; 2012 Oct; 35(4):149-53. PubMed ID: 23063087 [TBL] [Abstract][Full Text] [Related]
54. Prospective repair of Ventral Hernia Working Group type 3 and 4 abdominal wall defects with condensed polytetrafluoroethylene (MotifMESH) mesh. Cheesborough JE; Liu J; Hsu D; Dumanian GA Am J Surg; 2016 Jan; 211(1):1-10. PubMed ID: 26184351 [TBL] [Abstract][Full Text] [Related]
56. Outcomes of a prospective multi-center trial of a second-generation composite mesh for open ventral hernia repair. Hanna EM; Byrd JF; Moskowitz M; Mann JW; Stockamp KT; Patel GN; Beneke MA; Millikan K; Iannitti DA Hernia; 2014 Feb; 18(1):81-9. PubMed ID: 23526091 [TBL] [Abstract][Full Text] [Related]
57. Maximizing mesh mileage: evaluating the long-term performance of a novel hybrid mesh for ventral hernia repair. Spurzem GJ; Broderick RC; Li JZ; Sandler BJ; Horgan S; Jacobsen GR Hernia; 2024 Aug; 28(4):1151-1159. PubMed ID: 38429399 [TBL] [Abstract][Full Text] [Related]
58. Biosynthetic meshes in contaminated fields: where are we now? A systematic review and meta-analysis in humans. Perrone G; Giuffrida M; Bonati E; Petracca GL; Catena F Hernia; 2023 Aug; 27(4):765-780. PubMed ID: 36943520 [TBL] [Abstract][Full Text] [Related]
59. Safety and Efficacy of Synthetic Mesh for Ventral Hernia Repair in a Contaminated Field. Warren J; Desai SS; Boswell ND; Hancock BH; Abbad H; Ewing JA; Carbonell AM; Cobb WS J Am Coll Surg; 2020 Apr; 230(4):405-413. PubMed ID: 31954819 [TBL] [Abstract][Full Text] [Related]
60. Absorbable mesh in a contaminated field: hernia repair outcomes. Wagner V; Levy BE; Castle JT; Plymale M; Roth JS; Totten C Updates Surg; 2023 Aug; 75(5):1337-1342. PubMed ID: 36459367 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]